These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 18039470)

  • 1. FoxA1 as a lineage-specific oncogene in luminal type breast cancer.
    Yamaguchi N; Ito E; Azuma S; Honma R; Yanagisawa Y; Nishikawa A; Kawamura M; Imai J; Tatsuta K; Inoue J; Semba K; Watanabe S
    Biochem Biophys Res Commun; 2008 Jan; 365(4):711-7. PubMed ID: 18039470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Up-regulation of the HSP72 by Foxa1 in MCF-7 human breast cancer cell line.
    Song L; Xu Z; Zhang C; Qiao X; Huang C
    Biochem Biophys Res Commun; 2009 Aug; 386(1):30-4. PubMed ID: 19486887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FOXA1 is an independent prognostic marker for ER-positive breast cancer.
    Mehta RJ; Jain RK; Leung S; Choo J; Nielsen T; Huntsman D; Nakshatri H; Badve S
    Breast Cancer Res Treat; 2012 Feb; 131(3):881-90. PubMed ID: 21503684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Forkhead-box A1 (FOXA1) expression in breast cancer and its prognostic significance.
    Habashy HO; Powe DG; Rakha EA; Ball G; Paish C; Gee J; Nicholson RI; Ellis IO
    Eur J Cancer; 2008 Jul; 44(11):1541-51. PubMed ID: 18538561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FOXA1 is a potential oncogene in anaplastic thyroid carcinoma.
    Nucera C; Eeckhoute J; Finn S; Carroll JS; Ligon AH; Priolo C; Fadda G; Toner M; Sheils O; Attard M; Pontecorvi A; Nose V; Loda M; Brown M
    Clin Cancer Res; 2009 Jun; 15(11):3680-9. PubMed ID: 19470727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Collagen-induced morphogenesis and expression of the alpha 2-integrin subunit is inhibited in c-erbB2-transfected human mammary epithelial cells.
    D'Souza B; Berdichevsky F; Kyprianou N; Taylor-Papadimitriou J
    Oncogene; 1993 Jul; 8(7):1797-806. PubMed ID: 8099725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oestrogen-receptor-positive breast cancer: towards bridging histopathological and molecular classifications.
    Badve S; Nakshatri H
    J Clin Pathol; 2009 Jan; 62(1):6-12. PubMed ID: 18794199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of an autocrine neuregulin signaling loop with malignant transformation of human breast epithelial cells.
    Li Q; Ahmed S; Loeb JA
    Cancer Res; 2004 Oct; 64(19):7078-85. PubMed ID: 15466203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated expression of DecR1 impairs ErbB2/Neu-induced mammary tumor development.
    Ursini-Siegel J; Rajput AB; Lu H; Sanguin-Gendreau V; Zuo D; Papavasiliou V; Lavoie C; Turpin J; Cianflone K; Huntsman DG; Muller WJ
    Mol Cell Biol; 2007 Sep; 27(18):6361-71. PubMed ID: 17636013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptome characterization of human mammary cell lines expressing different levels of ERBB2 by serial analysis of gene expression.
    dos Santos ML; Palanch CG; Salaorni S; Da Silva WA; Nagai MA
    Int J Oncol; 2006 Jun; 28(6):1441-61. PubMed ID: 16685446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physical and functional interactions between homeodomain NKX2.1 and winged helix/forkhead FOXA1 in lung epithelial cells.
    Minoo P; Hu L; Xing Y; Zhu NL; Chen H; Li M; Borok Z; Li C
    Mol Cell Biol; 2007 Mar; 27(6):2155-65. PubMed ID: 17220277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tip30 controls differentiation of murine mammary luminal progenitor to estrogen receptor-positive luminal cell through regulating FoxA1 expression.
    Chen F; Li A; Gao S; Hollern D; Williams M; Liu F; VanSickle EA; Andrechek E; Zhang C; Yang C; Luo R; Xiao H
    Cell Death Dis; 2014 May; 5(5):e1242. PubMed ID: 24853420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FOXA1 represses the molecular phenotype of basal breast cancer cells.
    Bernardo GM; Bebek G; Ginther CL; Sizemore ST; Lozada KL; Miedler JD; Anderson LA; Godwin AK; Abdul-Karim FW; Slamon DJ; Keri RA
    Oncogene; 2013 Jan; 32(5):554-63. PubMed ID: 22391567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro assessment of adhesion molecules expression by human endothelial cells cocultured with c-erbB2-positive and c-erbB2-negative breast carcinoma cell lines.
    Markowska A; Urasińska E; Domagała W
    Pol J Pathol; 2008; 59(1):49-54. PubMed ID: 18655371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulation of lactate dehydrogenase A by ErbB2 through heat shock factor 1 promotes breast cancer cell glycolysis and growth.
    Zhao YH; Zhou M; Liu H; Ding Y; Khong HT; Yu D; Fodstad O; Tan M
    Oncogene; 2009 Oct; 28(42):3689-701. PubMed ID: 19668225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-tumor effect of honokiol alone and in combination with other anti-cancer agents in breast cancer.
    Liu H; Zang C; Emde A; Planas-Silva MD; Rosche M; Kühnl A; Schulz CO; Elstner E; Possinger K; Eucker J
    Eur J Pharmacol; 2008 Sep; 591(1-3):43-51. PubMed ID: 18588872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A negative feedback regulatory loop associates the tyrosine kinase receptor ERBB2 and the transcription factor GATA4 in breast cancer cells.
    Hua G; Zhu B; Rosa F; Deblon N; Adélaïde J; Kahn-Perlès B; Birnbaum D; Imbert J
    Mol Cancer Res; 2009 Mar; 7(3):402-14. PubMed ID: 19276186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Choline kinase down-regulation increases the effect of 5-fluorouracil in breast cancer cells.
    Mori N; Glunde K; Takagi T; Raman V; Bhujwalla ZM
    Cancer Res; 2007 Dec; 67(23):11284-90. PubMed ID: 18056454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours.
    Veeck J; Bektas N; Hartmann A; Kristiansen G; Heindrichs U; Knüchel R; Dahl E
    Breast Cancer Res; 2008; 10(5):R82. PubMed ID: 18826564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HDAC inhibitor SNDX-275 induces apoptosis in erbB2-overexpressing breast cancer cells via down-regulation of erbB3 expression.
    Huang X; Gao L; Wang S; Lee CK; Ordentlich P; Liu B
    Cancer Res; 2009 Nov; 69(21):8403-11. PubMed ID: 19826038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.